Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Astrana Health Inc. - Common Stock (NQ:ASTH)

37.08 +0.08 (+0.22%)
Delayed Quote Updated: 12:03 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Astrana Health Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
From Pomerantz LLP
Via GlobeNewswire
News headline image
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) ... 
Via StockStory
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH
From Pomerantz LLP
Via GlobeNewswire
News headline image
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
Astrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beat ↗
Via Chartmill
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentum ↗
Via Chartmill
News headline image
Why Astrana Health (ASTH) Shares Are Trading Lower Today
What Happened? Shares of healthcare services company Astrana Health fell 5.5% in the afternoon session after the company disclosed a "material" cybersecurity... 
Via StockStory
Topics Data Breach
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
From Pomerantz LLP
Via GlobeNewswire
News headline image
Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved Care Act, legislation aimed at re... 
Via StockStory
News headline image
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
Topics Energy
News headline image
2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
Astrana Health (ASTH) Q2 2026 Earnings Call Transcript ↗
Revenue jumped 49% to $972.5 million as adjusted EPS hit record $0.80. 
Via The Motley Fool
Topics Earnings Retirement
News headline image
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call
Astrana Health’s second quarter was met with a positive market response, as management highlighted several drivers behind the results. The company saw contin... 
Via StockStory
Topics Earnings
News headline image
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next ... 
Via StockStory
News headline image
Astrana Health Q2 Earnings Call Highlights ↗
Astrana Health (NASDAQ:ASTH) reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share... 
Via MarketBeat
Topics Earnings
News headline image
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1%
Healthcare services company Astrana Health fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million.... 
Via StockStory
News headline image
Astrana Health (ASTH) Q2 Earnings: What To Expect
Healthcare services company Astrana Health will be reporting results this Thursday after market hours. Here’s what to look for. Astrana Health beat analysts’... 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Reasons to Like ASTH and 1 to Stay Skeptical
The past six months have been a windfall for Astrana Health’s shareholders. The company’s stock price has jumped 79%, hitting $49.01 per share. This was part... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Profitable Stock to Target This Week and 2 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
News headline image
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
Topics Energy
News headline image
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil... 
Via StockStory
Topics Electric Vehicles
News headline image
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in... 
Via StockStory
News headline image
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in... 
Via StockStory
News headline image
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Mooning Stocks Worth Investigating and 1 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos... 
Via StockStory
Topics Initial Public Offering
News headline image
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call
Astrana Health’s first quarter was marked by progress in platform integration and the expansion of its AI-driven care model, leading to strong revenue growth... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations ↗
Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected... 
Via MarketBeat
Topics Bankruptcy
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.